Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma

BackgroundImmune checkpoint inhibitor (ICI)-combined chemotherapy in advanced intrahepatic cholangiocarcinoma has been proved to have more efficacy in a series of clinical trials. However, whether the tumor microenvironment (TME) plays a vital role in immune-combined therapy has not been rigorously...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Tian-mei Zeng, Yu-fei Pan, Zhen-gang Yuan, Dong-sheng Chen, Yun-jie Song, Yong Gao
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-09-01
coleção:	Frontiers in Immunology
Assuntos:	intrahepatic cholangiocarcinoma immunochemotherapy immune-related signature tumor microenvironment prognosis
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.943066/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!